Home / Dermatology
Dermatology
| 3 min read
Cellular Dynamics International Inc. (CDI) has announced that its researchers have generated pluripotent stem cells, which have the ability to generate all tissue types in the body, from very small volumes of ordinary human blood samples. This significant provides a readily obtainable source of pluripotent stem cells from the millions of samples in storage at blood repositories and healthcare institutions worldwide. CDI is the first company to say it can make stem cells from something as readily available, and so representative of human diversity, as blood.
| 4 min read
In the wake of lower-than-expected first-quarter results, Johnson & Johnson announced that it will be paring about 900 positions, or approximately 6 percent of its U.S. workforce, from its Ortho-McNeil-Janssen pharmaceuticals unit.
| 2 min read
After generating $108 million in U.S. sales last year, Raptiva linked to fatal brain infection PML
| 2 min read
OmegaGenesis, Mayo Clinic to develop nanomaterials for angiogenesis applications
| 2 min read
Milestone payments to total up to E32 million
| 3 min read
Silence Therapeutics and AstraZeneca strike new deal to design ways of delivering siRNA therapeutics
| 1 min read
In screening for binding partners for proteins, SPR and bioaffinity chromatography have traditionally been the methods of choice, but the systems can be compromised by debris found in cellular or botanical extracts.
| 2 min read
Ranbaxy Laboratories Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, recently announced that it acquired from Bristol-Myers Squibb Co. the U.S. rights to a group of 13 dermatology products.
| 2 min read
The world of biotech is certainly no stranger to promising claims, but nonetheless, Aruna Biomedical’s pops off the printed page: “To our knowledge, there has never been a human neural cell product offered that was derived from human embryonic stem cells.”
